4//SEC Filing
DEITCHER STEVEN R 4
Accession 0000914190-11-000056
CIK 0001140028other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:15 PM ET
Size
17.5 KB
Accession
0000914190-11-000056
Insider Transaction Report
Form 4
DEITCHER STEVEN R
DirectorPresident & CEO
Transactions
- Award
Common Stock
2011-02-02+179,192→ 184,192 total - Award
Stock Option (right to buy)
2010-11-01+62,500→ 312,500 totalExercise: $0.76Exp: 2020-02-16→ Common Stock (312,500 underlying)
Holdings
- 162,500
Stock Option (right to buy)
Exercise: $4.48Exp: 2017-12-14→ Common Stock (162,500 underlying) - 87,500
Stock Option (right to buy)
Exercise: $0.92Exp: 2020-06-07→ Common Stock (87,500 underlying) - 100,000
Stock Option (right to buy)
Exercise: $6.60Exp: 2017-05-21→ Common Stock (100,000 underlying) - 25,000
Stock Option (right to buy)
Exercise: $6.96Exp: 2017-08-24→ Common Stock (25,000 underlying) - 75,000
Stock Option (right to buy)
Exercise: $0.56Exp: 2019-02-24→ Common Stock (75,000 underlying) - 1,635,000
Stock Option (right to buy)
Exercise: $0.49Exp: 2020-12-21→ Common Stock (1,635,000 underlying)
Footnotes (6)
- [F1]On 9/10/10, the Company completed a one-for-four reverse stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to 9/10/10 have been adjusted to reflect the one-for-four reverse stock split.
- [F2]100% vested
- [F3]25,000 shares vest on each of 2/24/10, 2/24/11 and 2/24/12.
- [F4]On 2/16/10, the Reporting Person was granted an option (the "Standard Option") to purchase up to 250,000 shares of common stock, vesting as to one-third of the underlying shares on 2/16/11, with the remaining two-thirds vesting in 24 equal monthly installments thereafter. Also on 2/16/10, the Reporting Person was granted an option (the "Performance Option") to purchase up to 125,000 shares of common stock with the same vesting schedule as the Standard Option, provided that the vesting of the Performance Option was also conditioned upon the achievement of two specified regulatory milestones. On 11/1/10, it was determined that only one of the two milestones had been satisfied. As a result, the right to purchase 62,500 shares subject to the Performance Option is no longer conditioned upon the achievement of any milestone, and the right to purchase 62,500 shares subject to the Performance Option lapsed.
- [F5]One-third of the shares vest on 6/7/11 and the remaining two-thirds vest in 24 equal monthly installments thereafter.
- [F6]Shares vest in 48 equal monthly installments beginning 1/21/11.
Documents
Issuer
Talon Therapeutics, Inc.
CIK 0001140028
Entity typeother
Related Parties
1- filerCIK 0001400067
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:15 PM ET
- Size
- 17.5 KB